Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas.

about

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.

P2860

Q42316356-9879B9B4-E967-4D7D-83D1-D834D3FBBC3A Q53828417-63D2038A-BA14-4F65-8F23-19A21A38E5E0

P2860

Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas.

Item

http://www.wikidata.org/entity/Q35989647

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparison of gemcitabin, cisp ...... f peripheral T-cell lymphomas.

@ast

Comparison of gemcitabin, cisp ...... f peripheral T-cell lymphomas.

@en

type

Item

label

Comparison of gemcitabin, cisp ...... f peripheral T-cell lymphomas.

@ast

Comparison of gemcitabin, cisp ...... f peripheral T-cell lymphomas.

@en

prefLabel

Comparison of gemcitabin, cisp ...... f peripheral T-cell lymphomas.

@ast

Comparison of gemcitabin, cisp ...... f peripheral T-cell lymphomas.

@en

P1476

Comparison of gemcitabin, cisp ...... f peripheral T-cell lymphomas.

@en

P2093

Bo Jia

http://www.w3.org/2001/XMLSchema#string

Changgong Zhang

http://www.w3.org/2001/XMLSchema#string

Hua Lin

http://www.w3.org/2001/XMLSchema#string

Jianliang Yang

http://www.w3.org/2001/XMLSchema#string

Lin Gui

http://www.w3.org/2001/XMLSchema#string

Lin Wang

http://www.w3.org/2001/XMLSchema#string

Liqiang Zhou

http://www.w3.org/2001/XMLSchema#string

Mei Dong

http://www.w3.org/2001/XMLSchema#string

Peng Liu

http://www.w3.org/2001/XMLSchema#string

Puyuan Xing

http://www.w3.org/2001/XMLSchema#string

P2860

Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

How I treat the peripheral T-cell lymphomas

Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.

Therapy of peripheral T/NK neoplasms.

Management of peripheral T-cell non-Hodgkin's lymphoma.

Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.

Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome.

Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).

P304

536-541

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10245332.2016.1152084

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27077778

http://www.w3.org/2001/XMLSchema#string

P921

dexamethasone

Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas.

about

P2860

P2860

Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921